In comparison, both Dox-TCL- and SK-TCL-pulsed DCs expressed much higher levels of expression of CD91, TLR2 and TLR4 than those detected in immature or Naive-TCL loaded DCs, suggesting specific ICD component proteins from treated tumor cells can stimulate the expression of these PRRs. This evidence concerns the gene TLR2 and neoplasm.